A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer

Overview of attention for article published in BMC Research Notes, June 2015

Altmetric Badge

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 41 Mendeley

Summary Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

The differential prognostic implications of PD-L1 expression in the outcomes of Filipinos with EGFR -mutant NSCLC treated with tyrosine kinase inhibitors

Article in Translational Lung Cancer Research (September 2023)

Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF)

Article in Cancers (February 2022)

Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis

Article in PLOS ONE (July 2020)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.